These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11547947)

  • 1. Distribution and development of CLN2 protein, the late-infantile neuronal ceroid lipofuscinosis gene product.
    Kurachi Y; Oka A; Itoh M; Mizuguchi M; Hayashi M; Takashima S
    Acta Neuropathol; 2001 Jul; 102(1):20-6. PubMed ID: 11547947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical characterization of a lysosomal protease deficient in classical late infantile neuronal ceroid lipofuscinosis (LINCL) and development of an enzyme-based assay for diagnosis and exclusion of LINCL in human specimens and animal models.
    Sohar I; Sleat DE; Jadot M; Lobel P
    J Neurochem; 1999 Aug; 73(2):700-11. PubMed ID: 10428067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis.
    Crystal RG; Sondhi D; Hackett NR; Kaminsky SM; Worgall S; Stieg P; Souweidane M; Hosain S; Heier L; Ballon D; Dinner M; Wisniewski K; Kaplitt M; Greenwald BM; Howell JD; Strybing K; Dyke J; Voss H
    Hum Gene Ther; 2004 Nov; 15(11):1131-54. PubMed ID: 15610613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid immunologic diagnosis of classic late infantile neuronal ceroid lipofuscinosis.
    Kurachi Y; Oka A; Mizuguchi M; Ohkoshi Y; Sasaki M; Itoh M; Hayashi M; Goto Y; Takashima S
    Neurology; 2000 Apr; 54(8):1676-80. PubMed ID: 10762513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of late-infantile neuronal ceroid lipofuscinosis.
    Zhong N; Moroziewicz DN; Ju W; Jurkiewicz A; Johnston L; Wisniewski KE; Brown WT
    Genet Med; 2000; 2(6):312-8. PubMed ID: 11339651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and molecular characterization of neuronal ceroid lipofuscinosis in the Portuguese population.
    Teixeira C; Guimarães A; Bessa C; Ferreira MJ; Lopes L; Pinto E; Pinto R; Boustany RM; Sá Miranda MC; Ribeiro MG
    J Neurol; 2003 Jun; 250(6):661-7. PubMed ID: 12796825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCL.
    Sondhi D; Peterson DA; Giannaris EL; Sanders CT; Mendez BS; De B; Rostkowski AB; Blanchard B; Bjugstad K; Sladek JR; Redmond DE; Leopold PL; Kaminsky SM; Hackett NR; Crystal RG
    Gene Ther; 2005 Nov; 12(22):1618-32. PubMed ID: 16052206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal testing for late infantile neuronal ceroid lipofuscinosis.
    Berry-Kravis E; Sleat DE; Sohar I; Meyer P; Donnelly R; Lobel P
    Ann Neurol; 2000 Feb; 47(2):254-7. PubMed ID: 10665500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel CLN2/TPP1 mutation in a patient with late infantile neuronal ceroid lipofuscinosis.
    Yu F; Liu XM; Chen YH; Zhang SQ; Wang K
    Neurol Sci; 2015 Oct; 36(10):1917-9. PubMed ID: 26032578
    [No Abstract]   [Full Text] [Related]  

  • 10. Late infantile neuronal ceroid lipofuscinosis is due to splicing mutations in the CLN2 gene.
    Hartikainen JM; Ju W; Wisniewski KE; Moroziewicz DN; Kaczmarski AL; McLendon L; Zhong D; Suarez CT; Brown WT; Zhong N
    Mol Genet Metab; 1999 Jun; 67(2):162-8. PubMed ID: 10356316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of late infantile neuronal ceroid lipofuscinosis (CLN2) gene product in human brains.
    Oka A; Kurachi Y; Mizuguchi M; Hayashi M; Takashima S
    Neurosci Lett; 1998 Nov; 257(2):113-5. PubMed ID: 9865940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological deterioration in late infantile neuronal ceroid lipofuscinosis.
    Worgall S; Kekatpure MV; Heier L; Ballon D; Dyke JP; Shungu D; Mao X; Kosofsky B; Kaplitt MG; Souweidane MM; Sondhi D; Hackett NR; Hollmann C; Crystal RG
    Neurology; 2007 Aug; 69(6):521-35. PubMed ID: 17679671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two common mutations in the CLN2 gene underlie late infantile neuronal ceroid lipofuscinosis.
    Zhong N; Wisniewski KE; Hartikainen J; Ju W; Moroziewicz DN; McLendon L; Sklower Brooks SS; Brown WT
    Clin Genet; 1998 Sep; 54(3):234-8. PubMed ID: 9788728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased brain lysosomal pepstatin-insensitive proteinase activity in patients with neurodegenerative diseases.
    Junaid MA; Pullarkat RK
    Neurosci Lett; 1999 Apr; 264(1-3):157-60. PubMed ID: 10320038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis.
    Lin L; Lobel P
    Biochem J; 2001 Jul; 357(Pt 1):49-55. PubMed ID: 11415435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal localization of two genes underlying late-infantile neuronal ceroid lipofuscinosis.
    Haines JL; Boustany RM; Alroy J; Auger KJ; Shook KS; Terwedow H; Lerner TJ
    Neurogenetics; 1998 Mar; 1(3):217-22. PubMed ID: 10737126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal ceroid lipofuscinoses: research update.
    Wisniewski KE; Kida E; Connell F; Zhong N
    Neurol Sci; 2000; 21(3 Suppl):S49-56. PubMed ID: 11073228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A lysosomal proteinase, the late infantile neuronal ceroid lipofuscinosis gene (CLN2) product, is essential for degradation of a hydrophobic protein, the subunit c of ATP synthase.
    Ezaki J; Tanida I; Kanehagi N; Kominami E
    J Neurochem; 1999 Jun; 72(6):2573-82. PubMed ID: 10349869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tripeptidyl-peptidase I is apparently the CLN2 protein absent in classical late-infantile neuronal ceroid lipofuscinosis.
    Rawlings ND; Barrett AJ
    Biochim Biophys Acta; 1999 Jan; 1429(2):496-500. PubMed ID: 9989235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological studies on CLN2.
    Goebel HH; Kominami E; Neuen-Jacob E; Wheeler RB
    Eur J Paediatr Neurol; 2001; 5 Suppl A():203-7. PubMed ID: 11588998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.